Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Quantitative Susceptibility Mapping of Multiple Sclerosis Lesions at Various Ages.
Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects.
Neurological diseases in pregnancy.
Multicentre absolute myelin water content mapping: Development of a whole brain atlas and application to low-grade multiple sclerosis.
Structural and Functional Abnormalities of the Neuromuscular Junction in the Trembler-J Homozygote Mouse Model of Congenital Hypomyelinating Neuropathy.
Randomized controlled trial of a teleconference fatigue management plus physical activity intervention in adults with multiple sclerosis: rationale and research protocol.
Learning a cost function for microscope image segmentation.
Validity of an Observation Method for Assessing Pain Behavior in Individuals With Multiple Sclerosis.
Implementation of the 'Sapere Migliora' information aid for newly diagnosed people with multiple sclerosis in routine clinical practice: a late-phase controlled trial.
Multiple sclerosis: Diurnal variations in serum markers of inflammation-an avoidable source of bias in MS studies?
Insight into the conformational polymorph transformation of a block-buster multiple sclerosis drug fingolimod hydrochloride (FTY 720).
Neuromyelitis optica overlapping systemic sclerosis with anti-centromere antibodies.
Combining Self-help and Professional Help to Minimize Barriers to Physical Activity in Persons With Multiple Sclerosis: A Trial of the "Blue Prescription" Approach in New Zealand.
[New and future treatments for neurological disorders--knowledge essential to daily clinics and future prospects. Topics: 8. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
Detrusor sphincter dyssynergia: a review of physiology, diagnosis, and treatment strategies.
Changing face of multiple sclerosis in the United kingdom 1990-2010. An incidence and prevalence study.
Transglutaminase 2 exacerbates experimental autoimmune encephalomyelitis through positive regulation of encephalitogenic T cell differentiation and inflammation.
Madariaga Virus Infection Associated with a Case of Acute Disseminated Encephalomyelitis.
Inflammasomes and human autoimmunity: A comprehensive review.
Empyema presenting as lower extremity weakness.
Intrathecal CD4(+) and CD8(+) T cell responses to endogenously synthesized candidate disease-associated human autoantigens in multiple sclerosis patients.
Parallel changes in structural and functional measures of optic nerve myelination after optic neuritis.
Multiple sclerosis-associated retrovirus and related human endogenous retrovirus-W in patients with multiple sclerosis.
Genetic overlap between multiple sclerosis and several cardiovascular disease risk factors.
[Cognitive impairment in multiple sclerosis].
Pages
« first
‹ previous
…
397
398
399
400
401
402
403
404
405
…
next ›
last »